Enliven Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Enliven Therapeutics by T. Rowe Price Associates
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $298k | 12k | 25.59 |
2024-06-30 | $262k | 11k | 23.38 |